The data management approach of the CCNMD is a two tiered plan. Tier one, involves the implementation and maintenance of a data warehouse system that has recently been developed within the Department of Psychiatry center-wide. This system provides access to the contributing projects and cores within the CCNMD system integrated data storage and data query capacity through a secure web-based portal. A 3 server computer cluster and a 2 terabyte mass storage system positioned behind the Mount Sinai fire-wall and further protected by 128 bit encryption constitutes the physical structure for data management. All of the data tables generated by the Brian Bank Core and the Clinical Core during the past 22 years have been integrated into this browser based data warehouse which now contains over 3100 variables and more than 2 million data points. These data sets are available for interrogation and mining to all CCNMD participants through a secure intranet. Also included as part of the electronically available data sets are macro and microscopic images of Brain Bank tissues and PDF files of source documents on which the research data are based. Tier two, involves statistical support for all CCNMD projects and cores. All of the CCNMD projects require considerable statistical data analysis, and because of the complexity of some of the hypotheses addressed a high level of statistical analytic sophistication. While all of the CCNMD investigators are well versed in the statistical approaches that are applicable to their specific hypotheses and projects, this core will provide them with statistical expertise for not only state-of-the-art analysis of their specific data sets, but also for the integration of each projects data with the data derived from the other projects. The integration of cross-project data for statistical analysis will not only be aided by the data management system described, but also by the fact that statistical testing of hypotheses has been an integral part of the development of the aims and hypotheses of each CCNMD project form the time of their inception.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Specialized Center (P50)
Project #
3P50MH066392-09S1
Application #
8479525
Study Section
Special Emphasis Panel (ZMH1-ERB-S)
Project Start
Project End
Budget Start
2011-06-01
Budget End
2013-05-31
Support Year
9
Fiscal Year
2012
Total Cost
$74,420
Indirect Cost
$30,514
Name
Icahn School of Medicine at Mount Sinai
Department
Type
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Mueller, Toni M; Yates, Stefani D; Haroutunian, Vahram et al. (2016) Altered fucosyltransferase expression in the superior temporal gyrus of elderly patients with schizophrenia. Schizophr Res :
Lek, Monkol; Karczewski, Konrad J; Minikel, Eric V et al. (2016) Analysis of protein-coding genetic variation in 60,706 humans. Nature 536:285-91
Pinner, Anita L; Tucholski, Janusz; Haroutunian, Vahram et al. (2016) Decreased protein S-palmitoylation in dorsolateral prefrontal cortex in schizophrenia. Schizophr Res 177:78-87
Bhambhvani, Hriday P; Simmons, Micah; Haroutunian, Vahram et al. (2016) Decreased expression of cortactin in the schizophrenia brain. Neuroreport 27:145-50
Scott, Madeline R; Rubio, Maria D; Haroutunian, Vahram et al. (2016) Protein Expression of Proteasome Subunits in Elderly Patients with Schizophrenia. Neuropsychopharmacology 41:896-905
Fromer, Menachem; Roussos, Panos; Sieberts, Solveig K et al. (2016) Gene expression elucidates functional impact of polygenic risk for schizophrenia. Nat Neurosci 19:1442-1453
Sullivan, Courtney R; Funk, Adam J; Shan, Dan et al. (2015) Decreased chloride channel expression in the dorsolateral prefrontal cortex in schizophrenia. PLoS One 10:e0123158
Mueller, T M; Remedies, C E; Haroutunian, V et al. (2015) Abnormal subcellular localization of GABAA receptor subunits in schizophrenia brain. Transl Psychiatry 5:e612
Roussos, Panos; Katsel, Pavel; Fam, Peter et al. (2015) The triggering receptor expressed on myeloid cells 2 (TREM2) is associated with enhanced inflammation, neuropathological lesions and increased risk for Alzheimer's dementia. Alzheimers Dement 11:1163-70
Hertzberg, L; Katsel, P; Roussos, P et al. (2015) Integration of gene expression and GWAS results supports involvement of calcium signaling in Schizophrenia. Schizophr Res 164:92-9

Showing the most recent 10 out of 127 publications